October 31, 2017 to November 3, 2017
Europe/Berlin timezone

Session

Session 11: Clinical application III

Nov 3, 2017, 3:00 PM

Conveners

Session 11: Clinical application III

  • Jorge Camacho (Spanish National Research Council (CSIC))
  • Gursharan Sandhu (Delphinus Medical Technologies, Inc.)

Presentation materials

There are no materials yet.

  1. Frank Wolfram (Lung Cancer Centre SRH Waldklinikum Gera)
    11/3/17, 3:00 PM
    Main Track
    Oral
    During USCT examination, tissue morphology, as well as acoustic properties such as speed of sound are extracted. Data based upon malignant tissue is limited, so is its reliability as a prognostic factor indicating a malignant or benign nature. It’s hard to obtain tumour tissue because of their pathological use for staging. Therefore, this work will present a simple method of acoustic...
    Go to contribution page
  2. Jeffrey Bamber (Institute of Cancer Research)
    11/3/17, 3:20 PM
    Main Track
    Oral
    Softvue® (Delphinus Inc.) ultrasound tomography (UST) provides images of sound speed (SS), attenuation coefficient (AC), a combination of SS and AC called stiffness, and relative reflectivity. We have compared volume-averaged SS (VASS) with MRI volume-averaged water versus fat, to quantify breast density (O’Flynn et al., 2017). Here, clinical reproducibility is assessed, stiffness compared...
    Go to contribution page
  3. Hartmut Gemmeke (KIT-IPE)
    11/3/17, 3:40 PM
    Main Track
    Oral
    The first clinical studies with our current prototype, 3D USCT II, enabled us to identify the necessary improvements for transition of the method to clinical practice. The main goals are to improve the contrast of reflection tomography, the resolution of transmission tomography, and to optimize imaged volume of the breast. Furthermore, the fabrication of the transducer arrays needs to be...
    Go to contribution page
Building timetable...